Straumann Holding AG Other Share Holders Equity 2012-2021 | SAUHY

Straumann Holding AG other share holders equity from 2012 to 2021. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Straumann Holding AG other share holders equity for the quarter ending December 31, 2021 was $-0.449B, a 164.91% increase year-over-year.
  • Straumann Holding AG other share holders equity for 2021 was $-0.454B, a 13.59% increase from 2020.
  • Straumann Holding AG other share holders equity for 2020 was $-0.4B, a 83.49% increase from 2019.
  • Straumann Holding AG other share holders equity for 2019 was $-0.218B, a 26.08% increase from 2018.
Straumann Holding AG Annual Other Share Holders Equity
(Millions of US $)
2021 $-454
2020 $-400
2019 $-218
2018 $-173
2017 $-89
2016 $
2015 $-152
2014 $-144
2013 $-134
2012 $-109
2011 $-80
Straumann Holding AG Quarterly Other Share Holders Equity
(Millions of US $)
2021-12-31 $-449
2020-12-31 $-394
2020-06-30 $-346
2019-12-31 $-214
2018-12-31 $-169
2017-12-31 $-89
2017-06-30 $-114
2016-12-31 $0
2016-06-30 $-103
2015-12-31 $-152
2014-12-31 $-144
2013-12-31 $-134
2013-06-30 $-97
2012-12-31 $-109
2012-06-30 $-86
2011-12-31 $-80
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.137B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09